Clinical Trial Update: Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weekly docetaxel (Taxotere) in combination with topotecan for recurrent gynecologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• Hycamtin (Topotecan)
• Taxotere (docetaxel)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Ovarian Neoplasms, Uterine Neoplasms | Phase 2 | Status: COMPLETED